Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02535702 · ClinicalTrials.gov registry record · NA

Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction

A NA study of Normal Physiology, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).

Recruiting
Registry status
NA
Development phase
192
Enrollment target
1
Study location

NCT02535702 is a NA study of Normal Physiology that is actively recruiting participants, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). The registered enrollment target is 192 participants, below the 1,285-participant average among 25 other Normal Physiology trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02535702, a NA study of Normal Physiology, is actively recruiting participants, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).

RECRUITING
Registry status
NA
Development phase
192 participants
Enrollment target
1
Study location

Study Summary

Background: Abusing alcohol, drugs, and other substances can cause serious health problems. These substances also can affect brain function. Researchers want to learn more about brain function by using magnetic resonance imaging (MRI). This uses a magnetic field and radio waves to take pictures of the brain. Objective: To develop new ways to use MRI to study the brain. Eligibility: Healthy people 18 years of age or older. Design: Participants will be screened with a medical history, physical exam, and blood and urine tests. They will answer questions about their drug use and psychiatric history. They will be asked about family history of alcoholism or drug abuse. Participants will answer questions to see if they can participate in MRI. Participants will have MRI scans. The scanner is a metal cylinder in a strong magnetic field. Participants will lie on a table that slides in and out of the cylinder. A device called a coil may be placed over the head. Each sub-study will include up to 3 different MRI visits. Participants can be in multiple sub-studies. But they can have only 1 MRI per week and 20 per year. During MRI visits, participants may have urine collected. They may get another MRI questionnaire. Participants may have a clinical MRI brain scan. This may show physical problems in the brain. During some scans, participants may perform simple movement, memory, and thinking tasks. Participants may be connected to a machine to monitor brain activity during the scan. Small metal electrodes will be placed on the scalp. A gel will be placed in the space between the electrodes and the scalp. ...

Conditions Studied

Interventions

  • OTHER In vivo MRS
  • OTHER fMRI
  • OTHER EEG/EOG
  • OTHER Stimulation tasks
  • OTHER NSPRD

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 192 participants
Start Date 2016-06-28
Est. Completion 2026-12-31
Phase NA

What the Registry Record Tells You About NCT02535702

The ClinicalTrials.gov registry entry for NCT02535702 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 192 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,285-participant average among 25 other Normal Physiology trials with a reported enrollment target (85% lower). The listed sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Normal Physiology appearing as the primary indexed condition, and to 5 interventions - of which In vivo MRS is the first listed.

NCT02535702 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT02535702 about?

NCT02535702 is a clinical study titled "Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction". Background: Abusing alcohol, drugs, and other substances can cause serious health problems. These substances also can affect brain function. Researchers want to learn more about brain function by using magnetic resonance imaging (MRI). This uses a magnetic field and radio waves to take pictures of ...

What is the current status of trial NCT02535702?

This trial is currently recruiting. It is a NA study. The enrollment target is 192 participants. The study started on 2016-06-28. Estimated completion is 2026-12-31.

What conditions does trial NCT02535702 study?

This clinical trial studies the following conditions: Normal Physiology.

What interventions are being tested in trial NCT02535702?

The interventions under investigation include: In vivo MRS (OTHER), fMRI (OTHER), EEG/EOG (OTHER), Stimulation tasks (OTHER), NSPRD (OTHER).

Who is sponsoring clinical trial NCT02535702?

This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02535702 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Normal Physiology

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.